http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb1c3e8adb3bc60b85d20ef71e8422c8
Outgoing Links
Predicate | Object |
---|---|
family-name | Finn |
name | Stephen Finn |
given-name | Stephen |
organization-name | Departments of Histopathology, St. James's Hospital, Trinity College, Dublin, Ireland Labmed Directorate, St James’s Hospital, Dublin, Ireland;; Department of Histopathology, Trinity College Dublin, Ireland; From the Departments of Epidemiology, Biostatistics, and Nutrition, Harvard School of Public Health; Channing Laboratory and Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA; and the Department of Pathology and Laboratory Medicine, Weill Medical College, Cornell University, New York, NY. 4Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 9Department of Pathology, Trinity College, Dublin, Ireland. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; 2Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School; 2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; Departments of 3Epidemiology, 4Nutrition, and 5Biostatistics, Harvard School of Public Health; 6Radiation Oncology, Brigham and Women's Hospital; 7Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; 8Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; 9Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy; 10Uppsala University Hospital, Uppsala, Sweden; and 11The Broad Institute, Cambridge, Massachusetts Department of Histopathology St. James's Hospital Dublin Ireland St. James's Hospital, Dublin, Ireland. Department of Histopathology Central Pathology Laboratory Trinity College St James Hospital University of Dublin Ireland Department of Histopathology, Trinity College Medical School, Dublin, Ireland Authors' Affiliations: 1Channing Laboratory and 2Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 3Center for Molecular Oncologic Pathology, Dana Farber Cancer Institute; Departments of 4Epidemiology and 5Nutrition, Harvard School of Public Health; Boston, Massachusetts; 6Cancer Prevention Research Unit, Departments of Medicine and Oncology, Lady Davis Research Institute of the Jewish General Hospital and McGill University, Montreal, Quebec, Canada; 7South Asia Network for Chronic Disease, Public Health Foundation of India, New Delhi, India; and 8Department of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland 1Medical Oncology, Dana-Farber Cancer Institute and Authors' Affiliations: Departments of 1Nutrition, 2Epidemiology, and 3Biostatistics, Harvard School of Public Health; 4Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; 5Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital; Departments of 6Pathology and 7Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 8Molecular and Transplantation Pathology Laboratory, F. Addarii Institute of Oncology, University of Bologna, Bologna, Italy; 9Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; 10The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia; 11Department of Pathology & Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta; and 12Departments of Medicine and Oncology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada 1Center for Molecular Oncologic Pathology; Departments of; 7Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland From the Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Mass (Dr Finn); the Department of Molecular Pathology, University of Dublin, Trinity College, Trinity Centre for Health Sciences, St. James's Hospital (Drs Smyth, O'Leary, and Sheils, Ms Cahill, and Dr Flavin); the Department of Oral Pathology, Dublin Dental School and Hospital (Drs O'Regan and Toner); and the Departme Department of Pathology, St. James’s Hospital, Dublin, Ireland; Trinity College, Dublin, Ireland Authors' Affiliations: Departments of 1Epidemiology, 2Nutrition, and 3Biostatistics, Harvard School of Public Health; 4Channing Division of Network Medicine, Department of Medicine; Departments of 5Preventive Medicine and 6Pathology, Brigham and Women's Hospital and Harvard Medical School; 7Department of Pathology, Dana-Farber Cancer Institute, Boston; 8The Broad Institute, Cambridge, Massachusetts; 9Department of Histopathology Research, Trinity College, Dublin, Ireland; and 10Pathology Unit, Addarii Institute of Oncology, University of Bologna, Italy; Authors' Affiliations: Departments of 1Epidemiology, 2Nutrition, and 3Biostatistics, Harvard School of Public Health; 4Channing Division of Network Medicine, Department of Medicine; Departments of 5Preventive Medicine and 6Pathology, Brigham and Women's Hospital and Harvard Medical School; 7Department of Pathology, Dana-Farber Cancer Institute, Boston; 8The Broad Institute, Cambridge, Massachusetts; 9Department of Histopathology Research, Trinity College, Dublin, Ireland; and 10Pathology Unit, Addarii Institute of Oncology, University of Bologna, Italy Department of Pathology St. James's Hospital and Trinity College Dublin Dublin Ireland Department of Histopathology Research, Trinity College, Dublin, Ireland Department of Histopathology St. James's Hospital and Trinity College Dublin Medical School Dublin Ireland From Harvard School of Public Health; Harvard Medical School; Harvard Radiation Oncology Program; Channing Laboratory, Brigham and Women's Hospital; Dana-Farber Cancer Institute, Boston; The Broad Institute, Cambridge; MA; Uppsala University, Uppsala; Karolinska Institutet, Stockholm; Örebro University Hospital, Örebro, Sweden; Comprehensive Cancer Center, University Hospital of Tuebingen, Tuebingen, Germany; University of Brescia, Brescia, Italy; and Weill Cornell Medical College, New York, NY. Eve O’Reilly, Alexandra V. Tuzova, Niamh M. Russell, Gavin Clarke, Olivia Schmidt, William M. Gallagher, and Antoinette S. Perry, University College Dublin; Eve O’Reilly, Alexandra V. Tuzova, Anna L. Walsh, Sarah Kelly, Odharna Ni Dhomhnallain, Liam DeBarra, Connie M. Dale, Rick Brugman, Shane O’Meachair, Rustom P. Manecksha, and Antoinette S. Perry, Trinity College Dublin; Anna L. Walsh, Odharnaith O’Brien, Stephen Finn, and Rustom P. Manecksha, St James’s Hospital; Elizabeth McEvoy and Rustom P.... School of Chemical Sciences, Dublin City University, Dublin, Ireland Department of Histopathology, Central Pathology Department, St. James’s Hospital, Dublin 8, Ireland Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Department of Pathology, Trinity College Dublin, Dublin, Ireland. From the Dana-Farber Cancer Institute; Brigham & Women's Hospital; Children's Hospital Boston; Harvard School of Public Health, Harvard Medical School, Boston; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA; and University of Southern California Keck School of Medicine, Los Angeles, CA. |
Incoming Links
Total number of triples: 102.